Sarepta Therapeutics, Inc. SRPT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $330.96M+174% | -$282.85M-278% | -$179.95M-635% | —— | -$447.51M-1,339% | ||
| $10.59M+6.2% | $5.25M-49.8% | $18.45M+88.2% | $10.84M+24.3% | $9.98M+14.1% | ||
| $29.4M-29.0% | $30.02M-39.6% | $14.93M-65.6% | $37.03M-26.7% | $41.43M+1.8% | ||
| -$202.68M+65.3% | —— | -$14.59M+79.4% | —— | -$583.44M-141% | ||
| $2.08M-95.2% | $3.59M-90.6% | $22.93M-38.5% | $31.8M+9.0% | $43.65M+34.5% | ||
| -$134.39M+53.8% | $96.21M-87.4% | —— | —— | -$291.18M-233% | ||
| $250M— | —— | —— | —— | $0— | ||
| $250M— | $35.09M— | —— | —— | $0— | ||
| $241K-98.1% | -$39.21M-180% | -$117.79M-956% | -$23.82M-160% | $12.47M-43.7% | ||
| -$336.83M+60.9% | —— | —— | —— | -$862.14M-75,527% | ||
| -$204.76M+67.3% | —— | -$37.52M+65.2% | —— | -$627.09M-128% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sarepta Therapeutics, Inc. generate?
- Sarepta Therapeutics, Inc. (SRPT) generated -$871.4M in operating cash flow over the trailing twelve months.
- What is Sarepta Therapeutics, Inc.'s free cash flow?
- After $60.4M of capital expenditures, Sarepta Therapeutics, Inc.'s free cash flow was -$977.3M over the trailing twelve months, down 92.8% year over year.
- Where does Sarepta Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
